CASE REPORT
 
KEYWORDS
TOPICS
ABSTRACT
Neuromuscular disorders are a group of diseases which can result in severe development disorders. They can be demonstrated by many different symptoms. The case report presents the history of a patient who reported pain in the lower limbs and muscle weakness that made it difficult to move. Result of the EMG examination revealed neurogenic changes, suggesting the possibility of suffering from a motor variant of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), although not all the symptoms presented by the patient were characteristic. During subsequent hospitalizations, skin changes were noticed in the form of heliotropic erythema, which, based on a number of additional tests, finally led to the diagnosis of juvenile dermatomyositis. The occurrence of a neurological mask in the course of juvenile dermatomyositis indicates the need for a wide differential diagnosis.
Wróblewska K, Żybowska M, Piaszczyk Z, Miller K, Wieleba A, Szukała K, Chrościńska-Krawczyk M. Diagnostic difficulties of dermatomyositis – case report. J Pre-Clin Clin Res. 2024; 18(3): 282–285. doi: 10.26444/jpccr/192305
 
REFERENCES (19)
1.
Deenen JC, Horlings CG, Verschuuren JJ, et al. The Epidemiology of Neuromuscular Disorders: A Comprehensive Overview of the Literature. J Neuromuscul Dis. 2015;2(1):73–85. https://doi.org/10.3233/ JND-140045.
 
2.
McCann LJ, Livermore P, Wilkinson MGL, et al. Juvenile dermatomyositis. Where are we now? Clin Exp Rheumatol. 2022 Feb;40(2):394–403. https://doi.org/10.55563/cline....
 
3.
Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. Eur J Neurol. 2021 Nov;28(11):3556–3583. https://doi.org/10.1111/ ene.14959.
 
4.
Ponnala M, Mullen B, Nawab K, et al. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Overview, Treatment, and a Case Study. Cureus. 2023 Oct 22;15(10):e47475. https://doi.org/10.7759/ cureus.47475.
 
5.
Lewis RA, van Doorn PA, Sommer C. Tips in navigating the diagnostic complexities of chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Sci. 2022 Dec 15;443:120478. https:// doi.org/10.1016/j.jns.2022.120478
 
6.
Ryan M, Ryan SJ. Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health. Am J Manag Care. 2018 Sep;24(17 Suppl):S371–S379. PMID: 30312032, 24. S371–S379.
 
7.
Rhim JW. Juvenile Dermatomyositis. J Rheum Dis. 2022;29(1):14–21. https://doi.org/10.4078/jrd.20....
 
8.
Li D, Tansley SL. Juvenile Dermatomyositis-Clinical Phenotypes. Curr Rheumatol Rep. 2019 Dec 11;21(12):74. https:/ doi.org/10.1007/s11926-019-0871-4.
 
9.
Mamyrova G, Kishi T, Targoff IN, et al. Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis. Rheumatology (Oxford). 2018;57(11):1956–1963. https://doi.org/10.1093/ rheumatology/key190.
 
10.
Bunschoten C, Jacobs BC, Van den Bergh PYK, et al. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Lancet Neurol. 2019 Aug;18(8):784–794. https://doi.org/10.1016/S1474-....
 
11.
Vallat JM, Sommer C, Magy L. Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. Lancet Neurol. 2010 Apr;9(4):402–12. https://doi. org/10.1016/S1474-4422(10)70041-7.
 
12.
Chen H, Huang X, Bao Y, et al. The diagnostic value of quantitative assessment of MR neurography in chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Br J Radiol. 2023 Nov;96(1151):20221037. https://doi.org/10.1259/bjr.20....
 
13.
Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. Eur J Neurol. 2021 Nov;28(11):3556–3583. https://doi.org/10.1111/ene.14....
 
14.
Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision. Journal of the Peripheral Nervous System. 26(3):242–268. https://doi. org/10.1111/jns.12455.
 
15.
Barreto LC, Oliveira FS, Nunes PS, de França Costa IM, et al. Epidemiologic Study of Charcot-Marie-Tooth Disease: A Systematic Review. Neuroepidemiology. 2016;46(3):157–65. https://doi.org/10.1159/000443....
 
16.
Quartier P, Gherardi RK. Juvenile dermatomyositis. Handb Clin Neurol. 2013;113:1457–63. https://doi.org/10.1016/B978-0....
 
17.
Wu JQ, Lu MP, Reed AM. Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment. World J Pediatr. 2020 Feb;16(1):31–43. https://doi.org/10.1007/s12519....
 
18.
Patil A, Lu J, Kassir M, Babaei M, Goldust M. Adult and juvenile dermatomyositis treatment. J Cosmet Dermatol. 2023 Feb;22(2):395–401. doi:https://doi.org/10.1111/jocd.1....
 
19.
Swafford C, Roach ES. Juvenile Dermatomyositis and the Inflammatory Myopathies. Semin Neurol. 2020 Jun;40(3):342–348. doi:https://doi.org/10.1055/s-0040....
 
eISSN:1898-7516
ISSN:1898-2395
Journals System - logo
Scroll to top